ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 164 filers reported holding ALLOGENE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 2.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $50,727 | -61.3% | 16,155 | +40.5% | 0.00% | – |
| Q2 2022 | $131,000 | -49.8% | 11,500 | -59.5% | 0.00% | – |
| Q1 2022 | $261,000 | +4.0% | 28,429 | +69.7% | 0.00% | – |
| Q4 2021 | $251,000 | -64.0% | 16,749 | -38.1% | 0.00% | -100.0% |
| Q3 2021 | $698,000 | -37.2% | 27,067 | -36.3% | 0.00% | 0.0% |
| Q2 2021 | $1,111,000 | +173.6% | 42,460 | +269.2% | 0.00% | – |
| Q1 2021 | $406,000 | +2.8% | 11,500 | -26.3% | 0.00% | -100.0% |
| Q4 2020 | $395,000 | -37.7% | 15,610 | -6.9% | 0.00% | 0.0% |
| Q3 2020 | $634,000 | +28.9% | 16,766 | +45.8% | 0.00% | 0.0% |
| Q2 2020 | $492,000 | +100.8% | 11,500 | -11.1% | 0.00% | 0.0% |
| Q1 2020 | $245,000 | – | 12,939 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $16,381,000 | 9.53% |
| Wildcat Capital Management, LLC | 2,128,370 | $19,389,000 | 4.96% |
| TPG GP A, LLC | 18,716,306 | $170,506,000 | 2.11% |
| Pier Capital, LLC | 746,669 | $6,802,000 | 0.87% |
| Coastal Bridge Advisors, LLC | 401,929 | $3,662,000 | 0.84% |
| HARBOR CAPITAL ADVISORS, INC. | 92,755 | $845,000 | 0.40% |
| Lombard Odier Asset Management (Switzerland) SA | 501,219 | $4,566,000 | 0.36% |
| Navalign, LLC | 74,271 | $623,000 | 0.26% |
| PDT Partners, LLC | 241,592 | $2,201,000 | 0.19% |
| GSA CAPITAL PARTNERS LLP | 148,804 | $1,356,000 | 0.18% |